Tokyo Tape
Sign in
← Hyuga Primary Care

Quarterly report · Q2

7133.TEDINET S100PKQH
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥3.2bn2022-04-01 → 2022-09-30StandaloneNet sales
Revenue¥5.8bn2021-04-01 → 2022-03-31StandaloneNet sales (5-year summary)
Revenue¥2.8bn2021-04-01 → 2021-09-30StandaloneNet sales
Operating income¥255m2022-04-01 → 2022-09-30StandaloneOperating income
Operating income¥226m2021-04-01 → 2021-09-30StandaloneOperating income
Ordinary income¥263m2022-04-01 → 2022-09-30StandaloneOrdinary income
Ordinary income¥506m2021-04-01 → 2022-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥223m2021-04-01 → 2021-09-30StandaloneOrdinary income
Profit before tax¥263m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax¥221m2021-04-01 → 2021-09-30StandaloneIncome before income taxes
Net income¥179m2022-04-01 → 2022-09-30StandaloneProfit loss
Net income¥328m2021-04-01 → 2022-03-31StandaloneNet income loss (5-year summary)
Net income¥145m2021-04-01 → 2021-09-30StandaloneProfit loss
Total assets¥2.8bnat 2022-09-30StandaloneAssets
Total assets¥2.5bnat 2022-03-31StandaloneAssets
Total assets¥2.2bnat 2021-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥1.5bnat 2022-09-30StandaloneLiabilities
Total liabilities¥1.5bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥1.3bnat 2022-09-30StandaloneNet assets
Net assets / equity¥1.1bnat 2022-03-31StandaloneNet assets
Net assets / equity¥755mat 2021-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥680mat 2022-09-30StandaloneCash and deposits
Cash and deposits¥720mat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥680mat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥720mat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥561mat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥538mat 2021-03-31dStandaloneCash and cash equivalents
Operating cash flow¥97m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥485m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥177m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥193m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥320m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥172m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥57m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥17m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥18m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥50.662022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥24.512022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥95.82021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥42.632021-04-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥20.812021-07-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥47.472022-04-01 → 2022-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥88.282021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
Equity ratio46.4%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio42.4%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio33.8%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued3,568,400at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,499,100at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued11,369at 2021-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30−¥39m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥199m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentsegment profit2022-04-01 → 2022-09-30¥11m
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2022-04-01 → 2022-09-30¥329m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥25m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥25m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentsegment profit2022-04-01 → 2022-09-30−¥8m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2022-04-01 → 2022-09-30¥160m
—segment totalrevenue2022-04-01 → 2022-09-30¥3.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥3.2bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥492m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥454m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30−¥8m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥154m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue2021-04-01 → 2021-09-30¥62m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue external2021-04-01 → 2021-09-30¥62m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentsegment profit2021-04-01 → 2021-09-30−¥849,000
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2021-04-01 → 2021-09-30¥2.5bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2021-04-01 → 2021-09-30¥2.5bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2021-04-01 → 2021-09-30¥262m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue2021-04-01 → 2021-09-30¥37m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue external2021-04-01 → 2021-09-30¥37m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentsegment profit2021-04-01 → 2021-09-30¥14m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2021-04-01 → 2021-09-30¥192m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2021-04-01 → 2021-09-30¥192m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2021-04-01 → 2021-09-30¥114m
—segment totalrevenue2021-04-01 → 2021-09-30¥2.8bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥2.8bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥388m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥380m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 437
ItemContextValueUnit
Subsidy income ope cfCurrentYTDDuration_NonConsolidatedMember-9054000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration_NonConsolidatedMember-31081000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration_NonConsolidatedMember-52960000JPY
Decrease increase in inventories ope cfPrior1YTDDuration_NonConsolidatedMember-15990000JPY
Decrease increase in inventories ope cfCurrentYTDDuration_NonConsolidatedMember-39612000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration_NonConsolidatedMember70766000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration_NonConsolidatedMember18944000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration_NonConsolidatedMember13030000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration_NonConsolidatedMember8707000JPY
Increase decrease in accrued expenses ope cfPrior1YTDDuration_NonConsolidatedMember2800000JPY
Increase decrease in accrued expenses ope cfCurrentYTDDuration_NonConsolidatedMember10679000JPY
Other net ope cfPrior1YTDDuration_NonConsolidatedMember-14650000JPY
Other net ope cfCurrentYTDDuration_NonConsolidatedMember-6369000JPY
Subtotal ope cfPrior1YTDDuration_NonConsolidatedMember242403000JPY
Subtotal ope cfCurrentYTDDuration_NonConsolidatedMember188928000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration_NonConsolidatedMember45000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration_NonConsolidatedMember3000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration_NonConsolidatedMember-1353000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration_NonConsolidatedMember-851000JPY
Proceeds from subsidy ope cfPrior1YTDDuration_NonConsolidatedMember100000JPY
Proceeds from subsidy ope cfCurrentYTDDuration_NonConsolidatedMember9054000JPY
Income taxes paid ope cfPrior1YTDDuration_NonConsolidatedMember-64670000JPY
Income taxes paid ope cfCurrentYTDDuration_NonConsolidatedMember-100410000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration_NonConsolidatedMember176525000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration_NonConsolidatedMember96723000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration_NonConsolidatedMember-42676000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration_NonConsolidatedMember-40925000JPY
Purchase of intangible assets inv cfPrior1YTDDuration_NonConsolidatedMember-90534000JPY
Purchase of intangible assets inv cfCurrentYTDDuration_NonConsolidatedMember-89563000JPY
Payments for transfer of business2 inv cfPrior1YTDDuration_NonConsolidatedMember-36541000JPY
Payments for transfer of business2 inv cfCurrentYTDDuration_NonConsolidatedMember－JPY
Purchase of long term prepaid expenses inv cfPrior1YTDDuration_NonConsolidatedMember-231000JPY
Purchase of long term prepaid expenses inv cfCurrentYTDDuration_NonConsolidatedMember－JPY
Payments for lease and guarantee deposits inv cfPrior1YTDDuration_NonConsolidatedMember-2472000JPY
Payments for lease and guarantee deposits inv cfCurrentYTDDuration_NonConsolidatedMember-62714000JPY
Proceeds from collection of lease and guarantee deposits inv cfPrior1YTDDuration_NonConsolidatedMember118000JPY
Proceeds from collection of lease and guarantee deposits inv cfCurrentYTDDuration_NonConsolidatedMember58000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration_NonConsolidatedMember-172337000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration_NonConsolidatedMember-193145000JPY
Net increase decrease in short term loans payable fin cfPrior1YTDDuration_NonConsolidatedMember100000000JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration_NonConsolidatedMember100000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration_NonConsolidatedMember-81624000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration_NonConsolidatedMember-69788000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YTDDuration_NonConsolidatedMember－JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYTDDuration_NonConsolidatedMember26611000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration_NonConsolidatedMember18376000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration_NonConsolidatedMember56823000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember22563000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember-39599000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember538288000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass